Wave Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Wave Life Sciences 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About WVE

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. 

CEO
Paul B. Bolno
CEOPaul B. Bolno
Employees
317
Employees317
Headquarters
Singapore, Central Singapore
HeadquartersSingapore, Central Singapore
Founded
2012
Founded2012
Employees
317
Employees317

WVE Key Statistics

Market cap
2.48B
Market cap2.48B
Price-Earnings ratio
-10.89
Price-Earnings ratio-10.89
Dividend yield
Dividend yield
Average volume
2.52M
Average volume2.52M
High today
$14.19
High today$14.19
Low today
$13.11
Low today$13.11
Open price
$13.48
Open price$13.48
Volume
3.12M
Volume3.12M
52 Week high
$21.73
52 Week high$21.73
52 Week low
$5.28
52 Week low$5.28

Stock Snapshot

Wave Life Sciences(WVE) stock is priced at $13.75, giving the company a market capitalization of 2.48B. It carries a P/E multiple of -10.89.

During the trading session on 2026-03-05, Wave Life Sciences(WVE) shares reached a daily high of $14.19 and a low of $13.11. At a current price of $13.75, the stock is +4.9% higher than the low and still -3.1% under the high.

Trading volume for Wave Life Sciences(WVE) stock has reached 3.12M, versus its average volume of 2.52M.

The stock's 52-week range extends from a low of $5.28 to a high of $21.73.

The stock's 52-week range extends from a low of $5.28 to a high of $21.73.

WVE News

Simply Wall St 2d
Wave Life Sciences Obesity Proof Of Concept Sparks Focus On Pipeline Upside

Wave Life Sciences reported positive proof of concept for obesity candidate WVE-007 in Phase I, with fat loss and preservation of muscle mass. The company is p...

Wave Life Sciences Obesity Proof Of Concept Sparks Focus On Pipeline Upside
The Motley Fool 6d
Wave Life Sciences Earnings Call Transcript

Image source: The Motley Fool. Thursday, February 26, 2026 at 8:30 a.m. ET Call participants Chief Executive Officer — Paul Bolno Chief Medical Officer — Chris...

Wave Life Sciences Earnings Call Transcript

Analyst ratings

100%

of 18 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own WVE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.